enfusion is the leading provider of a cloud-based portfolio management and risk system. headquartered in chicago, illinois, with a branch office in new york, new york, and wholly-owned subsidiaries in london and hong kong, enfusion is a software company that focuses on delivering innovative solutions for clients in the financial services industry. our clients across the globe rely on our innovative real-time performance, risk calculations and accounting for some of the most sophisticated financial products. enfusion is undergoing exceptional growth and currently serves some of the world's largest and respected hedge funds with over 90 billion dollars of assets under management.
Company profile
Ticker
ENFN
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Microsoft • Oracle • Mobileye Global Inc - Ordinary Shares • Activision Blizzard • Gen Digital • Vmware • Adobe • Salesforce • BlackBerry • Dayforce ...
SEC CIK
Corporate docs
Subsidiaries
Enfusion Ltd. LLC • Enfusion US 1, Inc. • Enfusion US 2, Inc. • Enfusion US 3, Inc. • Enfusion Systems UK Ltd • Enfusion HK Limited • Enfusion Software Limited • Enfusion Softech India Private Limited • Enfusion (Singapore) Pte. Ltd. • Enfusion do Brasil Tecnologia da Informacão Ltd ...
ENFN stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
19 Mar 24
S-8
Registration of securities for employees
12 Mar 24
10-K
2023 FY
Annual report
12 Mar 24
8-K
Results of Operations and Financial Condition
12 Mar 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
8-K
Enfusion Announces Appointment of Chief Operating Officer
20 Nov 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Results of Operations and Financial Condition
7 Nov 23
8-K
Enfusion Announces Closing of New $100 Million Credit Facility
18 Sep 23
8-K
Unregistered Sales of Equity Securities
18 Aug 23
Transcripts
ENFN
Earnings call transcript
2023 Q4
12 Mar 24
ENFN
Earnings call transcript
2023 Q3
7 Nov 23
ENFN
Earnings call transcript
2023 Q2
8 Aug 23
ENFN
Earnings call transcript
2023 Q1
9 May 23
ENFN
Earnings call transcript
2022 Q4
7 Mar 23
ENFN
Earnings call transcript
2022 Q3
10 Nov 22
ENFN
Earnings call transcript
2022 Q2
13 Aug 22
ENFN
Earnings call transcript
2022 Q1
14 May 22
ENFN
Earnings call transcript
2021 Q4
25 Mar 22
ENFN
Earnings call transcript
2021 Q3
2 Dec 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 31.65 mm | 31.65 mm | 31.65 mm | 31.65 mm | 31.65 mm | 31.65 mm |
Cash burn (monthly) | (no burn) | 2.66 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 18.22 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 13.44 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 5.1 | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 92 |
Opened positions | 20 |
Closed positions | 23 |
Increased positions | 32 |
Reduced positions | 23 |
13F shares | Current |
---|---|
Total value | 512.03 bn |
Total shares | 138.94 mm |
Total puts | 86.40 k |
Total calls | 132.40 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
FTV Iv | 32.44 mm | $287.75 mm |
ICONIQ Capital | 14.04 mm | $157.52 bn |
ICONIQ Strategic Partners V | 14.04 mm | $0.00 |
Oleg Movchan | 13.02 mm | $0.00 |
Malherbe Investments | 11.87 mm | $248.57 mm |
LRA Ventures | 10.87 mm | $0.00 |
Brown Capital Management | 9.62 mm | $107.98 bn |
Hillhouse Capital Management | 4.98 mm | $0.00 |
Hillhouse Capital Advisors | 4.98 mm | $55.82 bn |
Werner Capital | 4.68 mm | $98.04 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Mar 24 | Oleg Movchan | Class A Common Stock | Grant | Acquire A | No | No | 0 | 149,701 | 0.00 | 529,473 |
5 Mar 24 | Oleg Movchan | Class A Common Stock | Grant | Acquire A | No | No | 0 | 100,000 | 0.00 | 379,772 |
1 Mar 24 | Oleg Movchan | Class A Common Stock | Payment of exercise | Dispose F | No | No | 8.67 | 4,069 | 35.28 k | 279,772 |
1 Mar 24 | Oleg Movchan | Class A Common Stock | Grant | Acquire A | No | No | 8.67 | 13,887 | 120.40 k | 283,841 |
1 Mar 24 | Neal Pawar | Class A Common Stock | Grant | Acquire A | No | No | 0 | 144,176 | 0.00 | 1,184,571 |
1 Mar 24 | Valeria Gutowski | Class A Common Stock | Payment of exercise | Dispose F | No | No | 8.67 | 1,051 | 9.11 k | 36,857 |
1 Mar 24 | Valeria Gutowski | Class A Common Stock | Grant | Acquire A | No | No | 8.67 | 3,036 | 26.32 k | 37,908 |
1 Mar 24 | Valeria Gutowski | Class A Common Stock | Grant | Acquire A | No | No | 0 | 17,302 | 0.00 | 34,872 |
1 Mar 24 | Bradley Herring | Class A Common Stock | Payment of exercise | Dispose F | No | No | 8.67 | 2,325 | 20.16 k | 294,946 |
1 Mar 24 | Bradley Herring | Class A Common Stock | Grant | Acquire A | No | No | 8.67 | 9,546 | 82.76 k | 297,271 |
News
Watching Enfusion; Spruce Point Capital Management Issues Short Report On Co, Says "Based On Our Investigation, We Estimate A 40% To 60% Downside Risk"
14 Mar 24
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
14 Mar 24
A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
13 Mar 24
B of A Securities Maintains Underperform on Enfusion, Raises Price Target to $9
13 Mar 24
Enfusion Expects 2024 Revenue of $200M-$210M Vs $202.3M Est
12 Mar 24
Press releases
Enfusion Announces Date of First Quarter 2024 Results
18 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
12 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
8 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
4 Apr 24
ConnexPay Appoints Ben Peters as Chief Executive Officer
2 Apr 24